Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Virtual Event

Apr 20, 2020 7:45 AM - Apr 21, 2020 2:45 PM

(US Eastern Standard Time)

Horsham, PA 19044

Global Labeling Conference

This event is now offered in a new entirely virtual format.

Session 1: Digital Labeling and Panel Discussion

Session Chair(s)

Rie  Matsui, RPh

Rie Matsui, RPh

Senior Director, Regional Labeling Head for APAC, International Labeling

Pfizer R&D Japan G.K., Japan

Deborah  Bebbington

Deborah Bebbington

Head Global Labeling

Bayer Plc, United Kingdom

There are many on-going initiatives of digital labeling across regions such as European Union, Japan, Canada and Singapore, although paper labeling is still required in majority of countries. eLabeling will help to deliver the latest labeling information immediately in efficient and customer friendly way for patients safety. Also, eLabeling is driven by the acceleration of digital disruption and must consider patient-centricity. In this session, the current landscape of eLabeling initiatives for future digital health across regions will be shared and will be discussed from regulators’ and industry’s point of view.

Learning Objective :

At the conclusion of this session, participants should be able to:

  • Understand the updates on eLabeling landscape across regions
  • Learn the company initiative on digital labeling
  • Discuss digital labeling for future digital health
  • Discuss the impact of eLabeling on company labeling process

Speaker(s)

Shinobu  Uzu, PhD

Speaker (Pre-recorded)

Shinobu Uzu, PhD

Pharmaceuticals and Medical Devices Agency (PMDA), Japan

Senior Executive Director

Craig  Anderson

Update on Health Canada's XML Product Monograph Project

Craig Anderson

Pfizer Inc , Canada

Director, R&D Lead, International Labeling Group

Aimad  Torqui

European Product Information – ePI Hot Air or Real Opportunities?

Aimad Torqui

Medicines Evaluation Board, Netherlands

Division Head Medicines Evaluation Board

Nathalie  Lambot, DrSc, MPharm, RPh

The Electronic Patient Leaflet Project (e-PIL) : A Pioneer Pilot in Belgium and Luxembourg

Nathalie Lambot, DrSc, MPharm, RPh

pharma.be , Belgium

Expert Santé Publique – Clinical Trials & Regulatory Affairs

Mark  Hendrickson, MS

Electronic Labeling: A U.S. Perspective

Mark Hendrickson, MS

Leavitt Partners, United States

Senior Director

Rie  Matsui, RPh

Asia Updates for E-Labeling

Rie Matsui, RPh

Pfizer R&D Japan G.K., Japan

Senior Director, Regional Labeling Head for APAC, International Labeling

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.